AMGEN INC (AMGN)
Healthcare · Biological Products, (No Diagnostic Substances)
AMGEN INC (AMGN) stock research on InvestAtlant: institutional ownership from 13F filings, insider Form 4 activity, and SEC context.
Top institutional holders (2026-Q3)
| Institution | Shares | Value | % Outstanding |
|---|---|---|---|
| Sumitomo Mitsui Trust Group, Inc. | 1,483,024 | $625.11M | 0.27% |
| Assenagon Asset Management S.A. | 1,080,066 | $455.26M | 0.20% |
| Mirae Asset Global Investments Co., Ltd. | 811,229 | — | 0.15% |
| Pictet Asset Management Holding SA | 770,033 | $324.96M | 0.14% |
| ProShare Advisors LLC | 713,097 | $300.58M | 0.13% |
| Robeco Institutional Asset Management B.V. | 675,485 | $284.72M | 0.12% |
| Smead Capital Management, Inc. | 586,504 | $247.22M | 0.11% |
| PRINCIPAL FINANCIAL GROUP INC | 566,131 | $238.63M | 0.10% |
Recent insider transactions
| Date | Insider | Title | Type | Value |
|---|---|---|---|---|
| 2026-08-13 | Khosla Rachna | SVP, Business Development | Sale | $521.4K |
| 2026-08-11 | Khosla Rachna | SVP, Business Development | Sale | $825.1K |
| 2026-08-06 | Miller Derek | SVP, Human Resources | Sale | $832.9K |
| 2026-08-06 | Miller Derek | SVP, Human Resources | Sale | $733.0K |
| 2026-08-06 | Grygiel Nancy A. | SVP & CCO | Sale | $792.3K |
| 2026-08-06 | Grygiel Nancy A. | SVP & CCO | Sale | $402.2K |